Frequently Asked Questions
The market is segmented based on , By Technique (PCR, ELISA, Direct Assays, Indirect Assays, DNA Staining, Microbial Culture Techniques, Enzymatic), Product (Kits and Reagent, Instruments, Others), Application (Cell Line Testing, Virus Testing, End-Of-Production Cell Testing, Other), End Users (Hospitals and Surgical Centers, Clinics, Community Healthcare, Others), Distribution Channel (Retail, Direct Tenders) – Industry Trends and Forecast to 2030.
.
The Global Mycoplasma Testing Market size was valued at USD 295.06 USD Million in 2022.
The Global Mycoplasma Testing Market is projected to grow at a CAGR of 7.5% during the forecast period of 2023 to 2030.
The major players operating in the market include AB ANALITICA s.r.l., BIOMÉRIEUX, ELITechGroup, Liofilchem S.r.l., Agilent Technologies , PromoCell GmbH, F. Hoffmann-La Roche Ltd, OSANG Healthcare, Sacace Biotechnologies Srl, Lonza, Merck KGaA, Seegene , Clongen Laboratories LLC, Bio-Rad Laboratories , Charles River Laboratories, Bionique Testing Laboratories LLC, ZEAKON Diagnostics
.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
